全球心臟瓣膜產業，到2028年的預測

投資創新技術創造成長機會

在本次分析中，Frost & Sullivan 涵蓋了心臟瓣膜產業，包括主動脈瓣、二尖瓣、三尖瓣和肺動脈瓣。它解決了市場規模、成長率、成長機會、策略要務、技術影響和行業開拓潛力等關鍵問題。

根據分析，由於經導管技術的日益採用，該行業獲得關注。經導管主動脈瓣置換術（TAVR）在過去幾年中取得了良好的成長，並且在預測期內可能會繼續成長。

產業相關人員開發經導管二尖瓣和三尖瓣技術，以抓住下一階段的成長機會。 Frost & Sullivan 認為，隨著許多新技術的發展以及這些技術的臨床證據和監管核准的增加，心臟瓣膜產業正處於曲折點。

目標區域為北美、歐洲、亞太地區、拉丁美洲和中東、非洲。由於存在許多大公司和新興企業，北美是最大的市場。由於受瓣膜性心臟病影響的人數眾多以及人們對瓣膜性心臟病技術的認知和可及性不斷提高，該行業在亞太地區快速成長。

研究期間為2021-2028年，其中2023年為基準年，2024-2028年為預測期間。

目錄

策略要務

• 為什麼成長越來越困難？
• The Strategic Imperative 8（TM）
• 關鍵策略要務對心臟瓣膜產業的影響
• 成長機會推動Growth Pipeline Engine（TM）

成長機會分析

• 心臟瓣膜
• 分析範圍
• 區隔
• 細分：產品範例
• 主要競爭對手
• 成長環境
• 概述
• 成長指標
• 生長促進因子
• 成長抑制因素
• 預測假設
• 收益預測
• 依細分市場分類的收益預測
• 依地區分類的收益預測
• 收益預測分析
• 依地區分類的收益預測分析
• 價格趨勢和預測分析
• 競爭環境
• 收益佔有率
• 收益佔有率分析
• 企業規劃：關鍵參與者
• 公司分佈圖：新興企業

心臟瓣膜疾病

• 心臟瓣膜疾病
• 環狀成形術環概述
• 心臟瓣膜裝置
• 年輕患者的 TAVR
• 擴大 TAVR 的應用
• 對三尖瓣和二尖瓣技術的需求
• 歐洲概況
• 亞太地區概覽
• 患者照護途徑
• 患者的活化增加了新的機會
• 患者參與

科技趨勢

• 影響心臟瓣膜產業的技術
• 人工智慧在心臟瓣膜疾病的應用
• 心臟瓣膜產業的Start-Ups公司
• 心臟瓣膜的臨床研究

成長機會分析：二尖瓣

• 成長指標
• 收益預測
• 依細分市場分類的收益預測
• 依地區分類的收益預測
• 預測分析

成長機會分析：主動脈瓣

• 成長指標
• 收益預測
• 依細分市場分類的收益預測
• 依地區分類的收益預測
• 預測分析

成長機會分析：三尖瓣

• 成長指標
• 收益預測
• 依地區分類的收益預測
• 預測分析

成長機會分析：肺瓣膜

• 成長指標
• 收益預測
• 依地區分類的收益預測
• 預測分析

成長機會宇宙

• 成長機會1：經導管二尖瓣和三尖瓣修復和置換
• 成長機會2：經導管主動脈瓣置換術
• 成長機會3：先進心臟瓣膜材料
• 成長機會4：亞太地區未滿足的需求

下一步

Investments in Innovative Technologies Enable Growth Opportunities

In this analysis, Frost & Sullivan covers the heart valves industry, including aortic, mitral, tricuspid, and pulmonary valves. We address critical questions such as market sizes, growth rates, opportunities, strategic imperatives, technology impact, and untapped potential in the industry.

Our analysis shows that the industry is gaining traction due to the increasing adoption of transcatheter technologies. Transcatheter aortic valve replacement (TAVR) procedures recorded lucrative growth in the past few years and will continue to grow in the forecast period.

Industry participants are developing transcatheter mitral and tricuspid valve technologies to capture the next growth phase. Frost & Sullivan finds that the heart valves industry has reached an inflection point due to the development of many new technologies as well as the rise in clinical evidence and regulatory approval for these technologies.

Regional coverage includes North America; Europe; Asia-Pacific; and Latin America, the Middle East, and Africa. North America is the largest market due to the presence of many large companies and emerging companies. The industry is growing rapidly in Asia-Pacific because of the high number of people suffering from heart valve diseases and growing awareness and accessibility to heart valve technologies.

The study period is 2021-2028, with 2023 as the base year and 2024-2028 as the forecast period.

Table of Contents

Strategic Imperatives

• Why is it Increasingly Difficult to Grow?
• The Strategic Imperative 8™
• The Impact of the Top 3 Strategic Imperatives on the Heart Valves Industry
• Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis

• Heart Valves
• Scope of Analysis
• Segmentation
• Segmentation: Product Examples
• Key Competitors
• Growth Environment
• Summary
• Growth Metrics
• Growth Drivers
• Growth Restraints
• Forecast Assumptions
• Revenue Forecast
• Revenue Forecast by Segment
• Revenue Forecast by Region
• Revenue Forecast Analysis
• Revenue Forecast Analysis by Region
• Pricing Trends and Forecast Analysis
• Competitive Environment
• Revenue Share
• Revenue Share Analysis
• Company Mapping: Major Players
• Company Mapping: Emerging Companies

Heart Valve Diseases

• Heart Valve Diseases
• Annuloplasty Rings Overview
• Heart Valve Devices
• TAVR in Young Patients
• Expanding TAVR Applications
• Demand for Tricuspid and Mitral Technologies
• Europe Overview
• Asia-Pacific Overview
• Patient Care Pathway
• Patient Activation Increases New Opportunities
• Patient Engagement

Technology Trends

• Technologies Affecting the Heart Valves Industry
• AI in Heart Valve Diseases
• Start-ups in the Heart Valves Industry
• Heart Valves in Clinical Research

Growth Opportunity Analysis: Mitral Valves

• Growth Metrics
• Revenue Forecast
• Revenue Forecast by Segment
• Revenue Forecast by Region
• Forecast Analysis

Growth Opportunity Analysis: Aortic Valves

• Growth Metrics
• Revenue Forecast
• Revenue Forecast by Segment
• Revenue Forecast by Region
• Forecast Analysis

Growth Opportunity Analysis: Tricuspid Valves

• Growth Metrics
• Revenue Forecast
• Revenue Forecast by Region
• Forecast Analysis

Growth Opportunity Analysis: Pulmonary Valves

• Growth Metrics
• Revenue Forecast
• Revenue Forecast by Region
• Forecast Analysis

Growth Opportunity Universe

• Growth Opportunity 1: Transcatheter Mitral and Tricuspid Valve Repair and Replacement
• Growth Opportunity 2: Transcatheter Aortic Valve Replacement
• Growth Opportunity 3: Advanced Heart Valve Materials
• Growth Opportunity 4: Unmet Needs in Asia-Pacific

Next Steps

• Your Next Steps
• Why Frost, Why Now?
• List of Exhibits
• Legal Disclaimer